Independence Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$628K Sell
7,930
-260
-3% -$20.4K 0.13% 46
2020
Q2
$604K Sell
8,190
-166
-2% -$12.5K 0.14% 44
2020
Q1
$613K Hold
8,356
0.17% 41
2019
Q4
$725K Sell
8,356
-9,537
-53% -$783K 0.18% 42
2019
Q3
$1.44M Buy
17,893
+9,490
+113% +$761K 0.35% 30
2019
Q2
$672K Buy
8,403
+399
+5% +$30.6K 0.17% 45
2019
Q1
$635K Hold
8,004
0.18% 47
2018
Q4
$584K Sell
8,004
-119
-1% -$8.4K 0.19% 44
2018
Q3
$550K Buy
8,123
+259
+3% +$16.5K 0.16% 42
2018
Q2
$455K Hold
7,864
0.15% 46
2018
Q1
$409K Sell
7,864
-265
-3% -$14.3K 0.13% 49
2017
Q4
$436K Hold
8,129
0.15% 46
2017
Q3
$497K Sell
8,129
-2,126
-21% -$129K 0.2% 37
2017
Q2
$627K Sell
10,255
-680
-6% -$41.4K 0.25% 35
2017
Q1
$663K Sell
10,935
-170
-2% -$10.3K 0.28% 34
2016
Q4
$624K Sell
11,105
-2,794
-20% -$164K 0.27% 35
2016
Q3
$828K Buy
13,899
+466
+3% +$27.3K 0.39% 28
2016
Q2
$738K Buy
+13,433
New +$715K 0.39% 24

Other funds holding MRK

Independence Advisors's MRK Position: Q3 2020 in Review

Independence Advisors reduced its Merck (MRK) stake by 3.2% in Q3 2020, selling an estimated $20.4K and leaving 7,930 shares worth $628K. The position accounts for 0.13% of the portfolio, ranked #46.

Independence Advisors first reported a position in MRK in Q2 2016 and has held it in 18 quarters since. The position peaked at $1.44M in Q3 2019. 2,558 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

  • Independence Advisors held 7,930 shares of Merck worth $628K as of Q3 2020.
  • Independence Advisors sold 260 Merck shares in Q3 2020, an estimated $20.4K.
  • Merck made up 0.13% of Independence Advisors's portfolio in Q3 2020, its #46 holding.
  • Independence Advisors first reported a position in Merck in Q2 2016 and has held it in 18 quarters since.
  • Independence Advisors's Merck position peaked at $1.44M in Q3 2019.
  • 2,558 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Independence Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.